Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as an additive to ropivacaine for interscalene brachial plexus block in shoulder surgery
2011-002175-42Phase 3Completed
- Sponsor
- Paracelsus Medical University
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in postoperative pain, sponsored by Paracelsus Medical University. Primary endpoint: Primary safety endpoint. Started Sep 2011; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2011-002175-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002175-42.